Effect of Lithium Carbonate on Postoperative Sleep and Cognitive Function in Patients Undergoing Heart Valve Surgery With Cardiopulmonary Bypass

NCT05593627 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2023-07-18

No results posted yet for this study

Summary

It has been proved that lithium carbonate can prolong slow wave sleep with few or no side-effects. The aim of the present study is to evaluate postoperative sleep quality of patients undergoing heart valve surgery with cardiopulmonary bypass taken 250mg lithium carbonate after surgery.

Conditions

  • Heart Valve Surgery

Interventions

DRUG

Lithium Carbonate 250 MG Oral Tablet

Patients undergoing heart valve surgery withcardiopulmonary bypass will take 250mg lithium carbonate

DRUG

Calcium Carbonate 500 MG Oral Tablet

Patients undergoing heart valve surgery withcardiopulmonary bypass will take 500mg calcium carbonate

Sponsors & Collaborators

  • China Medical University, China

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-01
Primary Completion
2025-12-31
Completion
2026-07-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05593627 on ClinicalTrials.gov